New drug MAR001 targets high triglycerides in early trial
Disease control
Completed
This study tested a new medicine, MAR001, in 55 adults with high triglycerides (a type of fat in the blood) and metabolic problems. The main goal was to see if the drug is safe and tolerable. Researchers also checked if it could lower triglyceride levels. The study was completed …
Phase: PHASE1, PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC